Results 141 to 150 of about 17,920 (197)

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption - A prospective monocenter pilot study. [PDF]

J Dtsch Dermatol Ges
Holtsche MM, van Beek N, Hammers CM, Vorobyev A, Kasperkiewicz M, Schumacher N, Muck P, Schmidt E.   +7 more
europepmc   +1 more source

A Specific Signature of Circulating Free Fatty Acid Discriminates Bullous Pemphigoid From Pemphigus Vulgaris and Healthy Controls. [PDF]

Exp Dermatol
Baldi S, Bertorello S, Cei F, Nannini G, Menicatti M, Niccolai E, Bartolucci G, Baffa ME, Pipitò C, Antiga E, Amedei A, Maglie R.   +11 more
europepmc   +1 more source

Association of <i>DPP4</i> Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid. [PDF]

Int J Mol Sci
Achilla C, Foutsitzidou C, Meltzanidou P, Patsatsi A, Lazaridou E, Tzatzagou G, Lambropoulos A, Chatzikyriakidou A.   +7 more
europepmc   +1 more source

Generalised Bullous Pemphigoid Following Fasciotomy - A Rare Occurrence. [PDF]

Indian Dermatol Online J
Patnaik S, Panda DR, Subudhi A, Panda PK.   +3 more
europepmc   +1 more source

Retrospective Evaluation of Omalizumab Treatment Efficacy in Patients with Bullous Pemphigoid. [PDF]

J Clin Med
Caf N, Türkoğlu Z, Özaydın Yavuz G, Doğan İ, Aydın SN, Atilla İK, Uzun H.   +6 more
europepmc   +1 more source

Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series. [PDF]

Oncologist
Nykaza I, Moy A, Dusza SW, Moskowitz A, Iyer G, Iqbal A, Motzer R, Ilson DH, O'Cearbhaill RE, Kazi R, Defazio J, Gordon A, Markova A.   +12 more
europepmc   +1 more source

Transition from Paraneoplastic Pemphigus to Bullous Pemphigoid after a 26-month Remission. [PDF]

Acta Derm Venereol
Matsumoto D, Mine M, Ishii N, Tsuruta D, Hiroyasu S.   +4 more
europepmc   +1 more source

Combination of Omalizumab and Dupilumab for the Treatment of Severe Bullous Pemphigoid: a Series of 6 Cases. [PDF]

Acta Derm Venereol
Boisseau R, Scaramuzzino L, Bernard P, Bedane C, Fourmond S.   +4 more
europepmc   +1 more source

Case Report: Dupilumab in difficult-to-treat bullous pemphigoid at the University Hospital Schleswig-Holstein, Campus Kiel. [PDF]

Front Med (Lausanne)
Mehrjerdian Y, Atallah R, Wijaya B, Hammers CM, Gerdes S, Heine G.   +5 more
europepmc   +1 more source

AMA-Negative Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome Presenting With Bullous Pemphigoid: A Case Report. [PDF]

Clin Case Rep
Haque T, Ansari RS, Rahman A, Gul F, Fareed A, Qayyum SN.   +5 more
europepmc   +1 more source